Evidence map›Paper›PMID 36722653›Full record

ArticleAutism research : official journal of the International Society for Autism Research2023

Consistency and reliability of automated language measures across expressive language samples in autism.

Heather MacFarlane, Alexandra C Salem, Steven Bedrick, Jill K Dolata, Jack Wiedrick, Grace O Lawley, Lizbeth H Finestack, Sara T Kover, Angela John Thurman, Leonard Abbeduto and 1 more

Abstract read
In one paragraph

Article in Autism research : official journal of the International Society for Autism Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Expressive Language Sample Concordance With ADOS-2 Scores: Autism, Down Syndrome, Fragile X Syndrome.American journal on intellectual and developmental disabilities · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Heather MacFarlaneDepartment of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0003-3834-2340
Alexandra C SalemDepartment of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-0645-8472
Steven BedrickDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-0163-9397
Jill K DolataDepartment of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-2231-5543
Jack WiedrickBiostatistics & Design Program, Oregon Health & Science University, Portland, Oregon, USA.
Grace O LawleyComputer Science and Electrical Engineering, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-8265-6411
Lizbeth H FinestackDepartment of Speech-Language-Hearing Sciences, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-5300-9282
Sara T KoverDepartment of Speech and Hearing Sciences, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8299-7585
Angela John ThurmanMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0003-4220-7897
Leonard AbbedutoMIND Institute, University of California Davis Health, Sacramento, California, USA.ORCID 0000-0002-2311-7194
Eric FombonneDepartment of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0002-8605-3538

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Computational characterization of language use in autism spectrum disorderR01DC012033 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI FOMBONNE, ERIC · 2011 to 2021
$6.7M
Expressive Language Sampling as an Outcome MeasureR01HD074346 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ABBEDUTO, LEONARD J. · 2013 to 2017
$3.9M
NCATS NIH HHS UL1 TR001860NCATS NIH HHS UL1 TR002369NICHD NIH HHS P50 HD103526NICHD NIH HHS R01 HD074346NIDCD NIH HHS R01 DC012033
6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with substantial clinical heterogeneity, especially in language and communication ability. There is a need for validated language outcome measures that show sensitivity to true change for this population. We used Natural Language Processing to analyze expressive language transcripts of 64 highly-verbal children and young adults (age: 6-23 years, mean 12.8 years; 78.1% male) with ASD to examine the validity across language sampling context and test-retest reliability of six previously validated Automated Language Measures (ALMs), including Mean Length of Utterance in Morphemes, Number of Distinct Word Roots, C-units per minute, unintelligible proportion, um rate, and repetition proportion. Three expressive language samples were collected at baseline and again 4 weeks later. These samples comprised interview tasks from the Autism Diagnostic Observation Schedule (ADOS-2) Modules 3 and 4, a conversation task, and a narration task. The influence of language sampling context on each ALM was estimated using either generalized linear mixed-effects models or generalized linear models, adjusted for age, sex, and IQ. The 4 weeks test-retest reliability was evaluated using Lin's Concordance Correlation Coefficient (CCC). The three different sampling contexts were associated with significantly (P < 0.001) different distributions for each ALM. With one exception (repetition proportion), ALMs also showed good test-retest reliability (median CCC: 0.73-0.88) when measured within the same context. Taken in conjunction with our previous work establishing their construct validity, this study demonstrates further critical psychometric properties of ALMs and their promising potential as language outcome measures for ASD research.

Indexed as

Autism Spectrum DisorderAutistic DisorderAdolescentAdultChildCommunicationFemaleHumansLanguageMaleReproducibility of ResultsYoung Adultautismautomated measurescommunicationexpressive languagenatural language processing

Identifiers

PMID36722653
PMCPMC10123085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.